Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 642,100 | 428,700 | 628,400 | 546,900 | 474,400 |
Receivables | 1,784,800 | 1,680,700 | 1,758,000 | 1,666,500 | 1,589,700 |
Inventories | 1,287,000 | 1,171,000 | 1,167,000 | 1,135,400 | 1,095,400 |
Other current assets | 374,300 | 338,100 | 382,400 | 355,100 | 333,200 |
TOTAL | $4,088,200 | $3,618,500 | $3,935,800 | $3,703,900 | $3,492,700 |
Non-Current Assets | |||||
PPE Net | 3,082,300 | 3,015,200 | 2,831,700 | 2,774,800 | 2,715,000 |
Intangibles | 3,252,900 | 3,116,800 | 3,072,000 | 2,954,700 | 2,920,200 |
Other Non-Current Assets | 386,000 | 361,500 | 244,200 | 247,200 | 229,700 |
TOTAL | $6,721,200 | $6,493,500 | $6,147,900 | $5,976,700 | $5,864,900 |
Total Assets | $10,809,400 | $10,112,000 | $10,083,700 | $9,680,600 | $9,357,600 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 139,400 | 138,100 | 637,100 | 609,900 | 787,900 |
Accounts payable and accrued liabilities | 1,130,900 | 1,066,800 | 1,036,000 | 993,400 | 1,005,200 |
TOTAL | $3,611,200 | $3,162,700 | $3,785,100 | $3,455,700 | $3,818,900 |
Non-Current Liabilities | |||||
Long Term Debt | 3,407,800 | 3,221,900 | 2,750,100 | 2,973,100 | 2,660,600 |
Other Non-Current Liabilities | 1,221,600 | 1,177,100 | 1,273,600 | 1,241,600 | 1,267,300 |
TOTAL | $4,946,000 | $4,663,100 | $4,276,500 | $4,453,600 | $4,120,900 |
Total Liabilities | $8,557,200 | $7,825,800 | $8,061,600 | $7,909,300 | $7,939,800 |
Shareholders' Equity | |||||
Shares Outstanding, K | 1,015,618 | 1,019,642 | 1,019,524 | 1,019,892 | 1,022,983 |
Common Shares | 732,900 | 732,900 | 732,900 | 732,900 | 732,900 |
Retained earnings | 10,704,700 | 10,627,500 | 10,411,800 | 10,177,900 | 9,775,000 |
Other shareholders' equity | -1,787,800 | -1,885,400 | -2,100,700 | -2,188,200 | -2,278,700 |
TOTAL | $2,252,200 | $2,286,200 | $2,022,100 | $1,771,300 | $1,417,800 |
Total Liabilities And Equity | $10,809,400 | $10,112,000 | $10,083,700 | $9,680,600 | $9,357,600 |